ZAHLER, Robert,CAI, Zhenwei,WU, Zhixing,VATH, James, E.
申请号：
PH12018500316
公开号：
PH12018500316A1
申请日:
2018.02.12
申请国别(地区):
PH
年份:
2018
代理人:
摘要：
Disclosed herein are fumagillol compounds of Formula (I) or Formula (Ia): wherein: Y is a bond or NR8； X is N or CRN； wherein X is N when Y is a bond and X is CRN when Y is NR8； n is 0 or 1； m is 1 or 2； Ring A may be optionally substituted by one or two substituents as defined； and R1 and R2, together with the carbon or carbons to which they are attached, form a 4-6 membered saturated heterocyclic ring B having one or two heteroatoms selected from the group consisting of O, S(O)w (wherein w is 0, 1 or 2) and NRh or form a 3-6 membered saturated carbocyclic ring B； wherein the heterocyclic or carbocyclic ring B may optionally be substituted as defined； and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
